Shengxian decoction decreases doxorubicin-induced cardiac apoptosis by regulating the TREM1/NF-κB signaling pathway

Shengxian decoction (SXT) is a traditional Chinese medicine that is clinically used for treating cardiovascular diseases. It is known for its beneficial effect on cardiomyocyte injuries, some of which can be induced by anticancer agents including doxorubicin (DOX). To determine the molecular mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Lei, Gui, Mingtai, Li, Jianhua, Lu, Bo, Wang, Jing, Zhou, Xunjie, Fu, Deyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845587/
https://www.ncbi.nlm.nih.gov/pubmed/33495812
http://dx.doi.org/10.3892/mmr.2021.11858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845587/
https://www.ncbi.nlm.nih.gov/pubmed/33495812
http://dx.doi.org/10.3892/mmr.2021.11858

Ejemplares similares